Omnyx, LLC
Inactive in EUDAMED since 2023United Statesfrom EUDAMED address EUDAMED SRN US-MF-000025160
Omnyx, LLC is a medical device manufacturer based in the United States, with 2 devices listed in FDA 510(k) and FDA GUDID (FDA Class II) and 1 FDA recall as of 20 Nov 2026.
Inactive. This company's EUDAMED actor record is marked inactive. Check the current status before ordering.
- Devices
- 2
- Registrations
- EUDAMED
- FDA recalls
- 1
Registry facts
- Registries
- FDA 510(k) 1
- FDA GUDID 1
- Device classes
- FDA Class II 2
- FDA recalls
- Identifiers
- EUDAMED SRN US-MF-000025160
- DUNS 002116917
At a glance
Market reach
- European Union
- EUDAMED actor
- United States
- FDA recalls
What Omnyx, LLC makes
Omnyx, LLC develops software applications for pathology information systems, including tools for digital pathology and manual application of diagnostic markers. Their products focus on managing cancer-related data and facilitating casefinding and abstracting processes within pathology workflows.
The company’s software portfolio is classified as Class II medical devices and is authorised through FDA pathways, including 510(k) clearances and the Unique Device Identifier (UDI) system. The products are listed under regulatory registries in the United States.
Catalogue
- Registry: GUDID
Omnyx Idp For HER2 Manual Application Ref K131140
Regimes: 510(k) Registry: 510(k)
Company details
- EUDAMED SRN
- US-MF-000025160
- DUNS number
- 002116917
- EUDAMED status
- Inactive since 2023
- EUDAMED registered name
- Omnyx, LLC
- Website
- www.inspirata.com
- facebook.com/InspirataCancerCare
- Phone
- +1 813 570 8976
- PRRC contact
- Richard Morroney, RAC, CQA
FDA recalls
FDA recall records list 1 recall initiated by Omnyx, LLC, initiated on 2013-10-01. By recorded status: 1 terminated. The reasons filed fall into these groups: software or firmware. A recall is often a precaution started by the manufacturer, and a count of records is not a verdict on a company.
2013
- 1 Oct 2013 Z-0469-2014 Class II Terminated There is an issue associated with Digital Pathology System (DPS) Software, in which the annotation tools within the DPS version 1.1 Image Viewer will display incorrect measurements and area calculations for a region of interest on a scanned slide, under certain conditions.
From the company website
Native AI cancer registry software for real-time casefinding, abstraction and reporting. One end-to-end oncology data platform with ONCO.
Frequently asked questions
How many devices does Omnyx, LLC have in the registry?
The registry currently lists 2 devices for Omnyx, LLC. Devices recorded under merged duplicate company entries are counted once.
Which registries list Omnyx, LLC's devices?
Among its 2 most recently registered devices, Omnyx, LLC has devices listed in FDA 510(k) (1 device) and FDA GUDID (1 device). A device can be listed in more than one registry, so these counts overlap.
What risk classes do Omnyx, LLC's devices fall under?
Among its 2 most recently registered devices, the classes recorded for Omnyx, LLC's devices are Class II. Each device page shows its own class and authorisation.
Are there FDA recall records for Omnyx, LLC?
FDA recall records list 1 recall initiated by Omnyx, LLC, the most recent initiated on 1 Oct 2013. A recall is often a precaution started by the manufacturer; the records say nothing about the company's overall record.
What are the newest devices from Omnyx, LLC in the registry?
The most recently registered devices listed for Omnyx, LLC include Dynamyx Digital Pathology Software 2.4 and OMNYX IDP FOR HER2 MANUAL APPLICATION.